dabigatran has been researched along with Kidney Failure, Chronic in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (94.74) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Assouline, S; Cohen, C; Cohen, S; Dhanjal, TS; Dib, JC; Dievart, F; Durand, P; Garban, T; Guedj-Meynier, D; Guenoun, M; Hoffman, O; Lellouche, N; Lequeux, B; Ouazana, L; Parrens, E; Pradeau, V; Sabouret, P; Schwartz, J; Sharareh, A; Villaceque, M | 1 |
| Bansal, VK; Choi, MJ; Herzog, CA; Jaar, BG; Kramer, H; Mehta, R; Rocco, MV; Sarnak, MJ | 1 |
| Mohebbi, N | 1 |
| Hu, A; Niu, J; Winkelmayer, WC | 1 |
| Artunc, F; Baumann, D; Haap, M; Jaschonek, K; Krämer, B; Peter, A; Rettig, I; Schreieck, J; Tsaousidis, C; Wallwiener, D | 1 |
| Chan, KE; Edelman, ER; Maddux, FW; Thadhani, RI; Wenger, JB | 1 |
| Gansser, D; Moschetti, V; Schmohl, M; Stangier, J | 1 |
| Brueckmann, M; Clemens, A; Kreuzer, J; Liesenfeld, KH; Schulze, F | 1 |
| Füessl, HS; Stiefelhagen, P | 1 |
| Abramson, S; Chan, KE; Giugliano, RP; Jardine, M; Maddux, FW; Patel, MR; Perkovic, V; Piccini, JP; Zhao, S | 1 |
| Assar, MD; Ball, T; Cox, KM; McCullough, PA | 1 |
| Keskar, V; Sood, MM | 1 |
| Cho, Y; Mills, K; Mudge, DW; Pillans, PI; Sturtevant, JM | 1 |
| Barez, A; Martínez, MP; Navarro-Dorado, J; Ramajo, M; Redondo, S; Tejerina, T | 1 |
| Finsterer, J; Rakusan, S; Stöllberger, C; Wimpissinger, FT | 1 |
| Koziński, M; Kubica, A; Kubica, J; Navarese, EP; Obońska, K | 1 |
| Alvarez, M; de Gea-García, JH; Jiménez-Parra, JD; Ruiz-Villa, G | 1 |
| McLellan, AJ; Schlaich, MP | 1 |
| Clemens, A; Formella, S; Friedman, J; Härtter, S; Khadzhynov, D; Lehr, T; Liesenfeld, KH; Moschetti, V; Neumayer, HH; Peters, H; Slowinski, T; Wagner, F; Wiegert, E | 1 |
6 review(s) available for dabigatran and Kidney Failure, Chronic
| Article | Year |
|---|---|
[The Multimorbid Patient: Use of New Oral Anticoagulants in Patients with Chronic Kidney Disease].
Topics: Anticoagulants; Arterial Occlusive Diseases; Atrial Fibrillation; Comorbidity; Contraindications; Coronary Disease; Dabigatran; Glomerular Filtration Rate; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thromboembolism; Vitamin K | 2018 |
Oral Anticoagulation in Patients With End-Stage Kidney Disease on Dialysis and Atrial Fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Rivaroxaban; Thiazoles; Thromboembolism; Warfarin | 2018 |
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF.
Topics: Anticoagulants; Atrial Fibrillation; Creatinine; Dabigatran; Glomerular Filtration Rate; Hemorrhage; Humans; Kidney; Kidney Failure, Chronic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Renal Insufficiency, Chronic; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2016 |
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Kidney Failure, Chronic; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Warfarin | 2016 |
Pharmacological basis and clinical evidence of dabigatran therapy.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Kidney Failure, Chronic; Thrombosis | 2011 |
[New oral anticoagulants - sunset for warfarin in therapy of atrial fibrillation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Electric Countershock; Factor Xa Inhibitors; Humans; Kidney Failure, Chronic; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Warfarin | 2012 |
1 trial(s) available for dabigatran and Kidney Failure, Chronic
| Article | Year |
|---|---|
Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease.
Topics: Adult; Antithrombins; Benzimidazoles; Berlin; beta-Alanine; Blood Coagulation; Dabigatran; Drug Administration Schedule; Humans; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Regression Analysis; Renal Dialysis | 2013 |
12 other study(ies) available for dabigatran and Kidney Failure, Chronic
| Article | Year |
|---|---|
Characteristics of patients with atrial fibrillation treated with direct oral anticoagulants and new insights into inappropriate dosing: results from the French National Prospective Registry: PAFF.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Kidney Failure, Chronic; Registries; Retrospective Studies; Rivaroxaban; Stroke | 2023 |
Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Kidney Failure, Chronic; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Renal Dialysis; Rivaroxaban; Stroke; Thiazoles; Warfarin | 2017 |
[Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014].
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Emergencies; Female; Humans; Kidney Failure, Chronic; Metabolic Clearance Rate; Uterine Hemorrhage | 2014 |
Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Databases, Factual; Dose-Response Relationship, Drug; Drug Utilization; Female; Hemorrhage; Hospitalization; Humans; Kidney; Kidney Failure, Chronic; Male; Matched-Pair Analysis; Middle Aged; Morpholines; Poisson Distribution; Practice Patterns, Physicians'; Renal Dialysis; Retrospective Studies; Risk; Rivaroxaban; Stroke; Thiophenes; Warfarin | 2015 |
Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Chromatography, Liquid; Dabigatran; Drug Monitoring; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Tandem Mass Spectrometry; Thrombin; Young Adult | 2015 |
Dabigatran treatment simulation in patients undergoing maintenance haemodialysis.
Topics: Administration, Oral; Aged; Anticoagulants; Area Under Curve; Atrial Fibrillation; Brain Ischemia; Computer Simulation; Dabigatran; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Stroke; Vitamin K | 2016 |
[Anticoagulation in low glomerular filtration rate].
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Contraindications; Dabigatran; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Guideline Adherence; Humans; Kidney Failure, Chronic; Male; Stroke | 2016 |
Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Kidney Failure, Chronic; Patient Selection; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin | 2016 |
Dabigatran may not be an effective anticoagulant for haemodialysis.
Topics: Aged, 80 and over; Anticoagulants; Benzimidazoles; Blood Coagulation; Dabigatran; Female; Humans; Kidney Failure, Chronic; Pyridines; Renal Dialysis; Treatment Failure | 2010 |
Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention.
Topics: Adenocarcinoma; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Bone Neoplasms; Brain Ischemia; Comorbidity; Dabigatran; Hematuria; Humans; Kidney Failure, Chronic; Leuprolide; Male; Prostatic Neoplasms; Pulmonary Disease, Chronic Obstructive; Secondary Prevention; Thrombophilia; Urinary Retention | 2012 |
[Wünderlich syndrome in patient anticoagulated with dabigatran].
Topics: Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Carcinoma, Transitional Cell; Dabigatran; Diabetes Mellitus, Type 2; Hematoma; Humans; Kidney Diseases; Kidney Failure, Chronic; Male; Nephrectomy; Pulmonary Disease, Chronic Obstructive; Retroperitoneal Space; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 2013 |
Dabigatran elimination: is haemodialysis effective?
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Kidney Failure, Chronic; Male; Renal Dialysis | 2013 |